Clinical Trial Update: Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030

View source ↗

Summary

This update describes a cancer genome study using samples from patients with stage I–II non-small cell lung cancer who were treated on the ACOSOG-Z0030 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Status: COMPLETED